Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMZ001 (diclofenac sodium gel) bioavailability study in healthy volunteers
NCT06729073Phase 1Completed
- Sponsor
- Amzell B.V.
- Start
- Nov 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of diclofenac (AMZ001 formulation) (2 arms), sponsored by Amzell B.V. Primary endpoint: Area Under the Curve 0-24 hours at 7 days. Started Nov 2024; status: completed.
02
Drugs
diclofenac (AMZ001 formulation)
Beyond the preview
Go deeper on NCT06729073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06729073.